RUNX1 Antikörper
Kurzübersicht für RUNX1 Antikörper (ABIN7540477)
Target
Alle RUNX1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Hersteller Produkt- Nr.
- 100-401-v33
-
Hersteller
- Rockland
-
Verwendungszweck
- AML1-ETO Antibody
-
Kreuzreaktivität (Details)
- This product reacts with human AML1-ETO.
-
Aufreinigung
- Anti-AML1-ETO Antibody is monospecific antiserum processed by delipidation and defibrination followed by sterile filtration.
-
Sterilität
- Sterile filtered
-
Immunogen
- Anti-AML1-ETO Antibody was produced in rabbits by repeated immunizations with a synthetic peptide of human AML1-ETO.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ChIP_Dilution: 4 μL/ChIP
ELISA_Dilution: 1:500
Western_Blot_Dilution: 1:1,000
-
Kommentare
-
Suggested Applications: Other
Anti-AML1-ETO Antibody has been tested in ChIP, ELISA and Western Blots. Specific conditions for reactivity should be optimized by the end user. Expect a band approximately 80 kDa in the appropriate cell lysate or extract. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Buffer: None
Stabilizer: None
Preservative: 0.05 % (w/v) Sodium Azide and 0.05 % ProClin 300 -
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
-
Haltbarkeit
- 12 months
-
-
-
: "HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90." in: Toxicology and applied pharmacology, Vol. 417, pp. 115459, (2021) (PubMed).
-
: "HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90." in: Toxicology and applied pharmacology, Vol. 417, pp. 115459, (2021) (PubMed).
-
- RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))
-
Andere Bezeichnung
- RUNX1
-
Hintergrund
- Runt-related transcription factor 1, Acute myeloid leukemia 1 protein, Core-binding factor subunit alpha-2, CBF-alpha-2, Oncogene AML-1, Polyomavirus enhancer-binding protein 2 alpha B subunit, PEA2-alpha B, PEBP2-alpha B, SL3-3 enhancer factor 1 alpha B subunit, SL3/AKV core-binding factor alpha B subunit,This antibody specifically recognizes the AML1 (RUNX1) (UniProtKB/Swiss-Prot entry Q01196) - ETO (RUNX1T1) (UniProtKB/Swiss-Prot entry Q06455) fusion protein that arises due to a translocation between chromosome 8 and 22. This translocation is one of the most frequent karyotypic abnormalities observed in acute myeloid leukemia. It produces a chimerical gene made up of the 5'-region of AML1and the 3'-region of ETO. The chimerical protein is thought to associate with the nuclear corepressor/histone deacetylase complex to block hematopoietic differentiation. Anti-AML1-ETO Antibody is ideal for research in Cancer and Gene Expression.
-
Gen-ID
- 861
-
NCBI Accession
- NP_001001890
-
UniProt
- Q01196
Target
-